Your browser doesn't support javascript.
Local and systemic responses to SARS-CoV-2 infection in children and adults.
Yoshida, Masahiro; Worlock, Kaylee B; Huang, Ni; Lindeboom, Rik G H; Butler, Colin R; Kumasaka, Natsuhiko; Dominguez Conde, Cecilia; Mamanova, Lira; Bolt, Liam; Richardson, Laura; Polanski, Krzysztof; Madissoon, Elo; Barnes, Josephine L; Allen-Hyttinen, Jessica; Kilich, Eliz; Jones, Brendan C; de Wilton, Angus; Wilbrey-Clark, Anna; Sungnak, Waradon; Pett, J Patrick; Weller, Juliane; Prigmore, Elena; Yung, Henry; Mehta, Puja; Saleh, Aarash; Saigal, Anita; Chu, Vivian; Cohen, Jonathan M; Cane, Clare; Iordanidou, Aikaterini; Shibuya, Soichi; Reuschl, Ann-Kathrin; Herczeg, Iván T; Argento, A Christine; Wunderink, Richard G; Smith, Sean B; Poor, Taylor A; Gao, Catherine A; Dematte, Jane E; Reynolds, Gary; Haniffa, Muzlifah; Bowyer, Georgina S; Coates, Matthew; Clatworthy, Menna R; Calero-Nieto, Fernando J; Göttgens, Berthold; O'Callaghan, Christopher; Sebire, Neil J; Jolly, Clare; De Coppi, Paolo.
  • Yoshida M; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Worlock KB; Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Huang N; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Lindeboom RGH; Wellcome Sanger Institute, Cambridge, UK.
  • Butler CR; Wellcome Sanger Institute, Cambridge, UK.
  • Kumasaka N; NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
  • Dominguez Conde C; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Mamanova L; Wellcome Sanger Institute, Cambridge, UK.
  • Bolt L; Wellcome Sanger Institute, Cambridge, UK.
  • Richardson L; Wellcome Sanger Institute, Cambridge, UK.
  • Polanski K; Wellcome Sanger Institute, Cambridge, UK.
  • Madissoon E; Wellcome Sanger Institute, Cambridge, UK.
  • Barnes JL; Wellcome Sanger Institute, Cambridge, UK.
  • Allen-Hyttinen J; Wellcome Sanger Institute, Cambridge, UK.
  • Kilich E; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK.
  • Jones BC; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • de Wilton A; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Wilbrey-Clark A; University College London Hospitals NHS Foundation Trust, London, UK.
  • Sungnak W; NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
  • Pett JP; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Weller J; University College London Hospitals NHS Foundation Trust, London, UK.
  • Prigmore E; Wellcome Sanger Institute, Cambridge, UK.
  • Yung H; Wellcome Sanger Institute, Cambridge, UK.
  • Mehta P; Wellcome Sanger Institute, Cambridge, UK.
  • Saleh A; Wellcome Sanger Institute, Cambridge, UK.
  • Saigal A; Wellcome Sanger Institute, Cambridge, UK.
  • Chu V; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Cohen JM; University College London Hospitals NHS Foundation Trust, London, UK.
  • Cane C; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Iordanidou A; University College London Hospitals NHS Foundation Trust, London, UK.
  • Shibuya S; Royal Free Hospital NHS Foundation Trust, London, UK.
  • Reuschl AK; Royal Free Hospital NHS Foundation Trust, London, UK.
  • Herczeg IT; Royal Free Hospital NHS Foundation Trust, London, UK.
  • Argento AC; University College London Hospitals NHS Foundation Trust, London, UK.
  • Wunderink RG; Royal Free Hospital NHS Foundation Trust, London, UK.
  • Smith SB; Royal Free Hospital NHS Foundation Trust, London, UK.
  • Poor TA; NIHR Great Ormond Street BRC and UCL Institute of Child Health, London, UK.
  • Gao CA; UCL Division of Infection and Immunity, University College London, London, UK.
  • Dematte JE; UCL Respiratory, Division of Medicine, University College London, London, UK.
  • Reynolds G; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Haniffa M; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Bowyer GS; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Coates M; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Clatworthy MR; Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Göttgens B; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • O'Callaghan C; Wellcome Sanger Institute, Cambridge, UK.
  • Sebire NJ; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Jolly C; Department of Medicine, University of Cambridge, Cambridge, UK.
  • De Coppi P; Department of Medicine, University of Cambridge, Cambridge, UK.
Nature ; 602(7896): 321-327, 2022 02.
Article in English | MEDLINE | ID: covidwho-1585831
ABSTRACT
It is not fully understood why COVID-19 is typically milder in children1-3. Here, to examine the differences between children and adults in their response to SARS-CoV-2 infection, we analysed paediatric and adult patients with COVID-19 as well as healthy control individuals (total n = 93) using single-cell multi-omic profiling of matched nasal, tracheal, bronchial and blood samples. In the airways of healthy paediatric individuals, we observed cells that were already in an interferon-activated state, which after SARS-CoV-2 infection was further induced especially in airway immune cells. We postulate that higher paediatric innate interferon responses restrict viral replication and disease progression. The systemic response in children was characterized by increases in naive lymphocytes and a depletion of natural killer cells, whereas, in adults, cytotoxic T cells and interferon-stimulated subpopulations were significantly increased. We provide evidence that dendritic cells initiate interferon signalling in early infection, and identify epithelial cell states associated with COVID-19 and age. Our matching nasal and blood data show a strong interferon response in the airways with the induction of systemic interferon-stimulated populations, which were substantially reduced in paediatric patients. Together, we provide several mechanisms that explain the milder clinical syndrome observed in children.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dendritic Cells / Killer Cells, Natural / T-Lymphocytes, Cytotoxic / Interferons / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Young adult Country/Region as subject: North America / Europa Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-021-04345-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Dendritic Cells / Killer Cells, Natural / T-Lymphocytes, Cytotoxic / Interferons / SARS-CoV-2 / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Young adult Country/Region as subject: North America / Europa Language: English Journal: Nature Year: 2022 Document Type: Article Affiliation country: S41586-021-04345-x